Advertisement
Advertisement

CAI

C

Caris Life Sciences, Inc. Common Stock

16.00
USD
Sponsored
-0.49
-3.00%
Jun 08, 15:18 UTC -4
Open

Caris Life Sciences, Inc. Common Stock Profile

About

Caris Life Sciences Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring and precision medicine enabling aspects. Caris Life Sciences Inc. is based in Irving, TX.

Info & Links

CEO

David Dean Halbert

Headquarters

750 W JOHN CARPENTER FREEWAY, SUITE 800
IRVING, TX 75039, UNITED STATES

Industry

Medical Services

Sector

Medical

Website

www.carislifesciences.com

Auditor

Deloitte & Touche LLP

Share holders

205

Employees

1,846

Caris Life Sciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

4.52B

Enterprise Value

4.08B

Enterprise Value/EBITDA(ttm)

28.66

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

9.38

Price to Cash(ytd)

12.04

Profitability

Gross Margin(ttm)

32.67%

Operating Margin(ttm)

--

Profit Margin(ttm)

-68.47%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-5.84%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

907.29M

Revenue Per Share(ttm)

3.21

Gross Profit(ttm)

623.45M

EBITDA(ttm)3

142.43M

Net Income Available to Common(ttm)

-435.89M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

--

S&P 500 52-Week Change

23.61%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

282.68M

Dividend Yield

0.00%

Float4

260.54M

% Held by Insiders

7.80%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

823.46M

Total Cash Per Share(mrq)

2.91

Total Debt(mrq)

381.57M

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

7.35%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement